Avoid common mistakes on your manuscript.
Correction to: American Journal of Clinical Dermatology https://doi.org/10.1007/s40257-023-00798-0
In the Acknowledgements section of this article the last sentence, which previously read:
“Medical writing was funded through a donation by AbbVie Srl.”
should have read:
“Medical writing was funded by SIDeMaST.”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Chiricozzi, A., Ortoncelli, M., Schena, D. et al. Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation. Am J Clin Dermatol 24, 963–964 (2023). https://doi.org/10.1007/s40257-023-00813-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-023-00813-4